OPDIVO sous-cutanée sol inj 600 mg/5 ml flac 1 pce

7680701920017 CH-70192 L01FF01 07.16.1.

Active substances:

Nivolumabum

No images available

Details

Product number
7019201
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Lösung: nivolumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, saccharum, acidum penteticum, polysorbatum 80, methioninum, aqua ad iniectabile, q.s. ad solutionem pro 5 ml.

Articles (1)

Opdivo subkutan 600 mg/5 ml, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
02/09/2026
Professional SmPC
Français
02/09/2026
Professional SmPC
Italien
02/09/2026

Detailed composition

Substance Quantity Type Category
nivolumabum
600.0 MG Substance Wirkstoff (Principe actif)
hyaluronidasum humanum ADNr
- Substance HNIDK
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
saccharum
- Substance HNIDK
acidum penteticum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
methioninum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 2969.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2026

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
70192
Drug name
Opdivo subkutan, Injektionslösung
Galenic form
LSINJ
ATC Code
L01FF01
Authorization status
Z
Dispensation category
A
First authorization
28/01/2026
Authorization expiration date
27/01/2031
IT number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
OPDIVO sous-cutanée sol inj 600 mg/5 ml flac 1 pce
Description (DE)
OPDIVO subkutan Inj Lös 600 mg/5 ml Durchstf 1 Stk
Market launch
01/09/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data